Melanoma Research Foundation Breakthrough Consortium
1 clinical trials · Sponsor
◉ Watch Melanoma Research Foundation Breakthrough Consortium
| Record | Firm | Date |
|---|---|---|
| Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma (NCT01495988) | Melanoma Research Foundation Breakthrough Consortium | 2013-08-01 |
Track Melanoma Research Foundation Breakthrough Consortium automatically
Every clearance here is in the API, with alerts when new ones post.